Persistent pulmonary hypertension of the newborn: Experience in a single Institution

Acta Paediatrica Taiwanica

Volumn 42, Issue 2, 2001, Pages 94-100

  Hsieh, W S ^a   Yang, P H ^a   Fu, R H ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Persistent pulmonary hypertension of the newborn; Tolazoline

Indexed keywords

TOLAZOLINE; VASODILATOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; ASPHYXIA; ASSISTED VENTILATION; CLINICAL ARTICLE; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HUMAN; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE; MALE; MECONIUM ASPIRATION; NEWBORN; NEWBORN CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; OXYGEN TENSION; PERSISTENT FETUS CIRCULATION; PNEUMONIA; PULMONARY HYPERTENSION; RASH; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

ARACHIDONIC ACID; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TOLAZOLINE; VASODILATOR AGENTS;

EID: 0035028132     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: An assessment of diffusion of innovation
2. Neonatal pulmonary hypertension: Pathophysiology, classification and etiology
3. The transitional circulation: Physiology and anesthetic implications
4. Treatment of persistent pulmonary hypertension of the newborn: Update
5. Pulmonary hypertension and persistent fetal circulation in the newborn
6. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy
7. Persistent pulmonary hypertension of the newborn, managing the unmanageable?
8. Drug therapy in persistent pulmonary hypertension of the newborn
9. Production of pulmonary vasodilation by tolazoline, independent of nitric oxide production in neonatal lambs
10. Non-hyperventilation respirator therapy of persistent pulmonary hypertension of the newborn
11. Persisten pulmonary hypertension in the neonate: Diagnosis and management
12. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation
13. Survival of infants with presistent pulmonary hypertension without extracorporeal membrane oxygenation
14. High-frequency jet ventilation in neonatal pulmonary hypertension
15. High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn
16. Extracorporeal membrane oxygenation: Controversies in selection of patients and management
17. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn
18. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn
19. Pulmonary complications of hyperventilation therapy for persistent pulmonary hypertension
20. Necrotizing tracheobronchitis: A complication of high frequency ventilation
21. Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension
22. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension
23. Controversies in management of persistent pulmonary hypertension of the newborn
24. National survey of diagnosis and management of persistent pulmonary hypertension of the newborn
25. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: A prospective randomized study
26. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn
27. Hyperventilation-induced cerebral hypoxia
28. The effects of active and passive hyperventilation on cerebral blood flow, cerebral oxygen consumption, cardiac output and blood pressure in normal young men
29. Hearing loss in infants with persistent fetal circulation
30. Persistent fetalcirculation: Neurodevelopemental outcome
31. Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn
32. Persistent pulmonary hypertension in the newborn
33. Magnesium surphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn
34. Prostaglandin E1 in primary pulmonary hypertension
35. Selective pulmonary vasodilation by low-dose infusion of adenosine triphosphate in newborn lambs
36. Selective drug therapy for pulmonary hypertension
37. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
38. Low-dose inhaltional intric oxide in persistent pulmonary hypertension of the newborn
39. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension
40. Inhaled nitric oxide
41. Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients
42. Inhaled nitric oxide can cause severe systemic hypotension
43. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure
44. Surfactant dysfunction after inhalation of nitric oxide
45. Bactericidal activity of peroxynitrite